1st Drug for Tardive Dyskinesia, Ingrezza (Valbenazine), Approved

WEDNESDAY, April 12, 2017 — Ingrezza (valbenazine), the first drug to treat adults with the neurological disorder tardive dyskinesia, has been approved by the U.S. Food and Drug Administration.
The disorder is characterized by repetitive…
Source: Topamax